Business Description
Disc Medicine is a clinical-stage company focused on developing new treatments for serious blood disorders. Founded in 2017 and based in Watertown, Massachusetts, the company is building a pipeline of medicines that target the biological processes controlling how red blood cells are made and how the body manages iron. Its leading drug candidates address conditions such as erythropoietic porphyrias, anemia linked to kidney disease and myelofibrosis, polycythemia vera, and anemia caused by inflammatory diseases.
